加味玉屏风散通过WT1/MVP介导的mTOR/AKT轴增强顺铂对非小细胞肺癌的疗效
本研究在顺铂耐药的A549/DDP非小细胞肺癌细胞中筛选与玉屏风散联用的中药提取物,发现银杏叶提取物增敏效果最强。加味玉屏风散(YPFS+GF)使顺铂诱导的毒性较单用玉屏风散提高2倍以上,其抗耐药机制与上调WT1、下调MVP及破坏mTORC2/AKT抗凋亡通路相关。
要点
- YPFS+GF较单用YPFS使DDP诱导的细胞毒性提高2倍以上。
- YPFS+GF抗耐药与WT1表达及活性升高、MVP转录水平降低相关。
- YPFS+GF破坏mTORC2/AKT通路,该效应可被胰岛素逆转、被PP242促进。
核心结论
- YPFS+GF在DDP处理的A549/DDP细胞中的抗耐药作用可能由下调WT1/MVP轴及下游mTORC2/AKT抗凋亡通路介导。
研究设计与样本
- 在顺铂耐药的A549/DDP非小细胞肺癌细胞中筛选与玉屏风散联用的中药提取物,以细胞毒性和凋亡检测评价增敏效果。
主要发现
- 银杏叶提取物在筛选中增敏效果最强,加味玉屏风散(YPFS+GF)使DDP诱导的毒性较单用YPFS提高2倍以上。
- YPFS+GF的增敏作用经诱导细胞凋亡得到证实,并伴随细胞内DDP浓度升高。
- YPFS+GF使WT1表达及活性升高,进而降低MVP转录水平。
- YPFS+GF破坏mTORC2/AKT通路,表现为Rictor、p-mTOR等mTORC2组分下降及AKT磷酸化水平降低。
- mTORC2诱导剂胰岛素可逆转、mTORC2抑制剂PP242可促进该通路破坏。
临床怎么用
- 该加味玉屏风散(YPFS+GF)在耐药非小细胞肺癌细胞中显示增强顺铂敏感性的潜力,支持中药作为肺癌辅助治疗的处方思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chemo-resistance is an obstacle in therapy of lung cancer. Alternative therapy of using herbal medicine has been proposed to resolve this obstacle. Yu Ping Feng San (YPFS), a common Chinese herbal medicinal mixture, has been reported to show anti-drug resistance on cisplatin (DDP), a common lung cancer drug. To optimize the anti-cancer function of YPFS, different Chinese herbal extracts having known function to overcome lung cancer were screened in combining with YPFS, as to increase the efficacy of DDP in drug resistance lung cancer cell, A549/DDP. Amongst these herbal extracts, Ginkgo Folium exhibited the most promoting sensitized effect. This revised herbal formula, named as YPFS+GF, promoted the DDP-induced toxicity by over 2-fold as compared to that of YPFS alone; this potentiation was confirmed by inducing cell apoptosis. The anti-drug resistance of YPFS, triggered by an increase of intracellular concentration of DDP, was accompanied by an increased expression and activity of WT1, which consequently decreased the transcript level of MVP. In addition, the MVP-mediated downstream effector mTOR2/AKT was disrupted after application of YPFS+GF in DDP-treated A549/DDP cell: this disruption was characterized by the decline of mTORC2 components, e.g., Rictor, p-mTOR, as well as the phosphorylation level of its downstream protein AKT. The disruption on mTORC2/AKT could be reversed by mTORC2 inducer insulin and promoted by mTORC2 inhibitor PP242. Thus, the anti-drug resistance of YPFS+GF in DDP-treated lung cancer cells might be mediated by the down regulation of WT1/MVP axis, as well as the downstream anti-apoptotic pathway of mTORC2/AKT signaling. Herbal medicine is one of the main adjuvant therapies in non-small cell lung cancer, and this novel herbal formula supports the prescription of traditional Chinese medicine in cancer treatment.
引用
- Lou JS, Xia YT, Wang HY, et al. The WT1/MVP-Mediated Stabilization on mTOR/AKT Axis Enhances the Effects of Cisplatin in Non-small Cell Lung Cancer by a Reformulated Yu Ping Feng San Herbal Preparation. Front Pharmacol. 2018. PMID: 30131696. doi:10.3389/fphar.2018.00853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。